Atea Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
November 08, 2023 at 04:44 pm EST
Atea Pharmaceuticals, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported net loss was USD 33.14 million compared to USD 8.07 million a year ago. Basic loss per share from continuing operations was USD 0.4 compared to USD 0.1 a year ago.
For the nine months, net loss was USD 96.79 million compared to USD 81.48 million a year ago. Basic loss per share from continuing operations was USD 1.16 compared to USD 0.98 a year ago.